'Adderall Alternative Vyvanse Is In Low Supply As ADHD Drug Shortages Spread' - Bloomberg News
Portfolio Pulse from Happy Mohamed
Bloomberg reports a low supply of Vyvanse, an alternative to Adderall, as ADHD drug shortages spread. Takeda Pharmaceutical (TAK) and Teva Pharmaceutical (TEVA) are mentioned in the article.
June 20, 2023 | 7:38 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Takeda Pharmaceutical (TAK) may face challenges due to the low supply of Vyvanse, an alternative to Adderall, as ADHD drug shortages spread.
Takeda Pharmaceutical is mentioned in the article as a company that may be affected by the low supply of Vyvanse. As ADHD drug shortages spread, it could negatively impact TAK's sales and revenue in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Teva Pharmaceutical (TEVA) may also be impacted by the low supply of Vyvanse, an alternative to Adderall, as ADHD drug shortages spread.
Teva Pharmaceutical is mentioned in the article as a company that may be affected by the low supply of Vyvanse. As ADHD drug shortages spread, it could negatively impact TEVA's sales and revenue in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80